Search Result "MAP Kinases"
Computational Insights for the Discovery of Non-ATP Competitive Inhibitors of MAP Kinases
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 9 Year: 2012 Page: 1173-1185
Author(s): Michael J. Schnieders, Tamer S. Kaoud, Chunli Yan, Kevin N. Dalby, Pengyu Ren
A Theoretical Investigation on the Pleiotropic Effects of Statins as p38 MAP Kinase Ligands
Journal: Letters in Drug Design & Discovery
Volume: 7 Issue: 8 Year: 2010 Page: 546-550
Author(s): Carla M.S. Menezes, Carolina M. Avila, Eliezer J. Barreiro
p38 MAP Kinase Mediated Proteoglycan Synthesis as a Target for the Prevention of Atherosclerosis
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 8 Issue: 4 Year: 2008 Page: 287-292
Author(s): Narin Osman, Mandy L. Ballinger, Harsha M. Dadlani, Robel Getachew, Micah L. Burch, Peter J. Little
Pyridinylimidazole Based p38 MAP Kinase Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 2 Issue: 9 Year: 2002 Page: 1011-1020
Author(s): Paul F. Jackson, James L. Bullington
Recent Developments of p38α MAP Kinase Inhibitors as Antiinflammatory Agents Based on the Imidazole Scaffolds
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 1 Year: 2013 Page: 1997-2016
Author(s): Ting-Ting Kong, Cheng-Mei Zhang, Zhao-Peng Liu
Interleukin-1 Drives Cerebrovascular Inflammation via MAP Kinase-Independent Pathways
Journal: Current Neurovascular Research
Volume: 7 Issue: 4 Year: 2010 Page: 330-340
Author(s): Peter Thornton, Barry W. McColl, Laura Cooper, Nancy J. Rothwell, Stuart M. Allan
Successful Structure-Based Design of Recent p38 MAP Kinase Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 9 Issue: 7 Year: 2009 Page: 655-676
Author(s): Solveigh C. Karcher, Stefan A. Laufer
Mitogen Activated Protein (MAP) Kinases: Development of ATP and Non- ATP Dependent Inhibitors
Journal: Medicinal Chemistry
Volume: 2 Issue: 2 Year: 2006 Page: 213-222
Author(s): Chad N. Hancock, Alba T. Macias, Alexander D. MacKerell, Jr., Paul Shapiro
Inhibitors and Activators of the p38 Mitogen-Activated MAP Kinase(MAPK) Family as Drugs to Treat Cancer and Inflammation
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 3 Year: 2022 Page: 209-220
Author(s): William A. Denny
MEK Inhibitors: A Therapeutic Approach to Targeting the Ras-MAP Kinase Pathway in Tumors
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 1907-1914
Author(s): Judith S. Sebolt-Leopold